Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 7, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	59	23	10	25	22	54	Upgrade
Market Cap Growth	154.01%	124.70%	-58.43%	13.56%	-59.44%	100.17%	Upgrade
Enterprise Value	59	23	12	23	13	49	Upgrade
Last Close Price	0.03	0.01	0.02	0.05	0.05	0.16	Upgrade
PS Ratio	17.44	18.56	4.87	11.73	19.57	-	Upgrade
PB Ratio	12.30	9.62	-98.80	1.17	0.88	2.25	Upgrade
P/TBV Ratio	16.82	9.62	-	1.17	0.88	2.25	Upgrade
EV/Sales Ratio	17.66	18.60	5.47	11.01	11.94	-	Upgrade
EV/FCF Ratio	-29.18	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.51	1.32	-32.26	0.20	0.20	0.16	Upgrade
Asset Turnover	0.36	0.16	0.11	0.06	0.03	-	Upgrade
Inventory Turnover	0.53	0.10	0.35	-	-	-	Upgrade
Quick Ratio	1.77	2.56	0.80	2.10	4.48	4.84	Upgrade
Current Ratio	2.46	3.62	1.16	2.44	4.48	4.84	Upgrade
Return on Equity (ROE)	-21.82%	-322.69%	-212.19%	-28.74%	-29.64%	-21.02%	Upgrade
Return on Assets (ROA)	-19.86%	-38.72%	-22.95%	-14.69%	-11.98%	-10.66%	Upgrade
Return on Capital (ROIC)	-28.29%	-66.59%	-30.88%	-17.84%	-14.42%	-12.77%	Upgrade
Earnings Yield	-1.36%	-16.05%	-217.12%	-26.61%	-33.04%	-10.40%	Upgrade
FCF Yield	-3.47%	-15.78%	-13.53%	-20.03%	-12.50%	-3.49%	Upgrade
Buyback Yield / Dilution	-218.05%	-184.48%	-8.13%	-6.46%	-21.70%	-16.15%	Upgrade

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.